Abstract:OBJECTIVES To clarify the inhibition of pancreatic cancer cells by interference with the hTR component of the telomerase reverse transcriptase enzymatic complex and evaluate susceptibility of antisense hTR pancreatic cancer cells to chemotherapeutic reagents. METHODS A 593 bp of full length hTR cDNA was subcloned into a mammalian expression vector pcDNA3.1(-) in antisense orientation to construct an antisense hTR expression plasmid. The plasmids were introduced into Pancl cells, a human pancreatic carcinoma cell line, by lipofectin, and G418-resistant stable transformants were expanded. Resulting stable clones were screened for the presence of hTR insert by PCR with T7 and BGH reverse primers located on the flanks of the multiclonal site of pcDNA3.1 vector. Cell growth rate, hTR expression, telomerase activity, and anchorage-independent growth property were analyzed. Finally, susceptibility of antisense hTR cells to chemotherapeutic reagents was evaluated. RESULTS Significant downregulation of endogenous hTR was evident in the antisense-hTR transformed cells, and telomerase activity was markedly decreased compared to control cells in standard TRAP assays. Furthermore, the proliferation and the anchorage-independent growth ability in antisense-hTR expressing cells were significantly decreased compared with the control parental cells. However, no crisis or senescence phenomena was observed. Antisense hTR appears to increase Pancl cell's susceptibility to chemotherapeutic reagent cDDP, but not to differentiation reagent DMSO, COX2 inhibitor sulinbac, NS-398, curcumin, and chemotherapeutic reagent adriamycin (ADM). CONCLUSIONS These data indicate that hTR is probably a critical component of human telomerase activity and that downregulation of the RNA component of human telomerase is an effective target for anticancer strategy and antisense hTR can increase Pancl cell's susceptibility to cDDP.

Inhibition of Telomerase Activity of Colorectal Cancer Cells by Chemotherapeutic Drugs

THE EFFECTS OF DIFFERENT DRUGS ON TELOMERASE ACTIVITY OF LIVER CANCER BEL-7404 CELL

Effects of chemotherapeutic drugs on telomer of human liver cancer BEL-7404 cell

Inhibition Effect of Homoharringtonine on Telomerase Activity of K562 Cells

Nonsteroidal Anti-Inflammatory Drugs Inhibit Human Telomerase Reverse Transcriptase (htert) in Gastric and Colon Cancer

[Effects of Cisplatin on Telomerase Activity of Human Choroidal Melanoma Cells].

CDDP Inhibition of Telomerase Activity in Uveal Melanoma Cells

Can Inhibition of Telomerase Increase Pancreatic Cancer Cell's Susceptibility to Chemotherapeutic Reagents?

Killing Effect of 5-fluorouracil and Cisplatin on Tongue Cancer in Vitro and Their Impact on Telomerase Activity

Inhibition of Docetaxel on Proliferation of Colon Cancer LoVo Cell Line

STUDY ON TUMOR CELL LINES AND THEIR TELOMERASE ACTIVITY BY TELOMERASE INHIBITORS

Inhibition on Telomerase Activity and Cytotoxic Effects by Cisplatin in Cultured Human Choroidal Melanoma Cells.

Effects of RNA Interference Polo-Like Kinase-1 Gene on Telomerase Activity of Human Colon Cancer Cell

Regulatory Effect of Chemotherapeutic Drugs(5-Fu,MMC,DDP) on the Expression of Tumor Suppressor Gene PTEN in Human Colon Cancer Cell

Downregulation of Telomerase Activity in Breast Cancer Impairs Cells Proliferation, Invasive Ability and Sensitizes Cells to Ultraviolet-Radiation and Adriamycin-Chemotherapy <i>in Vitro</i>

Sensitivity of different human colorectal tumor cell lines to commonly used chemotherapeutic drugs in vitro

Effects of curcumin on telomerase activity and on proliferation of human hepG2 cells

The Effects of Guanine-Quadruplexes Induced by Adriamycin on Telomerase and Cell Cycle of Tca8113 Cells

Research progress on anticancer therapeutics targeting telomere/telomerase

Inhibition of Telomerase Activity of Human Colon Cancer Cell Line by Compound Traditional Chinese Medicine Kang Ai Fang

Influence of Hydroxyapatite Nanoparticles on Growth and Telomerase Activity of Human Colon Carcinoma Cell Line SW-480